Article thumbnail

Novel serum proteomic signatures in a non-human primate model of retinal injury

By Jeffrey J. Dunmire, Rachida Bouhenni, Michael L. Hart, Bassam T. Wakim, Anthony M. Chomyk, Sarah E. Scott, Hiroshi Nakamura and Deepak P. Edward
Topics: Research Article
Publisher: Molecular Vision
OAI identifier: oai:pubmedcentral.nih.gov:3081796
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1973). A clinical and light microscopic study of the evolution of retinal lesions in the rhesus monkey.
  2. (2004). A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem
  3. (2005). A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation.
  4. (2007). Advances in proteomic workflows for systems biology. Curr Opin Biotechnol
  5. (2009). Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
  6. (2003). Argon laser photocoagulationinduced modification of gene expression in the retina. Invest Ophthalmol Vis Sci
  7. (1997). Argon laser retinal lesions evaluated in vivo by optical coherence tomography.
  8. (1999). blocking apoptosis and regulating gene expression in cultured retinal neurons. Biochem Pharmacol
  9. (1992). Blood-retinal barrier breakdown caused by diode vs argon laser endophotocoagulation. Arch Ophthalmol
  10. (2010). Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.
  11. (2003). Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics
  12. (2009). Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.
  13. (2005). Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics
  14. (2006). Comparison of spectral counting and metabolic stable isotope labeling for use with quantitative microbial proteomics. Analyst (Lond)
  15. (2000). Control of chemokine production at the blood-retina barrier. Immunology
  16. (2009). Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis
  17. (1998). Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol
  18. (1991). Cytoskeleton in normal and reactive human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci
  19. (2006). Detecting differential and correlated protein expression in label-free shotgun proteomics.
  20. (2004). Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett
  21. (2009). Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma. Mol Cancer Ther
  22. (1996). Elevation of an alpha(1,3)fucosyltransferase activity correlated with apoptosis in the human colon adenocarcinoma cell line, HT-29. Glycoconj J
  23. (2005). Eph/ephrin expression in the adult rat visual system following localized retinal lesions: localized and transneuronal up-regulation in the retina and superior colliculus.
  24. (2011). Experimental photocoagulation of the human retina. I. Correlation of physical, clinical, and Molecular Vision
  25. (1977). Experimental photocoagulation of the human retina. I. Correlation of physical, clinical, and pathologic data. Arch Ophthalmol
  26. (1993). Expression of alpha-(1,3)-fucosyltransferases which synthesize sialyl Le(x) and sialyl Le(a), the carbohydrate ligands for E- and P-selectins,in human malignant cell lines. Cancer Res
  27. (2001). Expression of glycoconjugates bearing the Lewis X epitope during neural differentiation of P19 EC cells.
  28. (1995). Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms.
  29. (2001). Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci
  30. (2000). FUT4 and FUT9 genes are expressed early in human embryogenesis. Glycobiology
  31. (2000). Graded expression of EphA3 in the retina and ephrin-A2 in the superior colliculus during initial development of coarse topography in the wallaby retinocollicular projection.
  32. (2011). High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids
  33. (1975). Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study.
  34. (1975). Human phosphoglycerate kinase. Methods Enzymol
  35. (2011). Identification of differentially expressed proteins in the aqueous humor of primary congenital glaucoma. Exp Eye Res
  36. (1994). Immunohistochemical localization of blood-retinal barrier breakdown after argon laser photocoagulation in the monkey retina. Nippon Ganka Gakkai Zasshi
  37. (2003). Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis.
  38. (1996). Induction of phosphoglycerate kinase 1 gene expression by hypoxia.
  39. (2004). Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res
  40. (2001). Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol
  41. (2008). Mechanisms of leukocyte migration across the blood-retina barrier. Semin Immunopathol
  42. (2009). Muller cell activation, proliferation and migration following laser injury.
  43. (2001). Neuron specific enolase in retinal detachment. Curr Eye Res
  44. (2009). Neuroprotein s-100B–a useful parameter in paediatric patients with mild traumatic brain injury? Acta Paediatr
  45. (1984). Ocular effects of various laser wavelengths. Surv Ophthalmol
  46. (1988). Patterns of cytokeratin and vimentin expression in the human eye. Histochemistry
  47. (1993). Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta). Neurology
  48. (2003). Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol
  49. (2007). Quantifying raft proteins in neonatal mouse brain by 'tubegel' protein digestion label-free shotgun proteomics. Proteome Sci
  50. (2008). Quantitative assessment of human serum high-abundance protein depletion. Electrophoresis
  51. (2000). Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke
  52. Repair after xenon arc photocoagulation.
  53. (1993). Restoration of the outer blood-retinal barrier after krypton laser photocoagulation. Ophthalmic Res
  54. (1973). Retinal repair after experimental xenon arc photocoagulation. I. A comparison between rhesus monkey and rabbit.
  55. (2006). Roles of Eph receptors and ephrins in the normal and damaged adult CNS. Brain Res Brain Res Rev
  56. (2008). Roles of ephrinas and structured activity in the development of functional maps in the superior colliculus.
  57. (1992). Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science
  58. (2010). Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.
  59. (2004). Temporal changes in gene expression after injury in the rat retina. Invest Ophthalmol Vis Sci
  60. (2010). Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.
  61. (1982). The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell
  62. (1988). The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo.
  63. (2002). The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics
  64. (2008). The Urine Proteome as a Biomarker of Radiation Injury: Submitted to Proteomics- Clinical Applications Special Issue: “Renal and Urinary Proteomics (Thongboonkerd). Proteomics Clin Appl
  65. (1970). Thermal and mechanical mechanisms in laser damage to the retina. Invest Ophthalmol
  66. (1998). Tissue effects of subclinical diode laser treatment of the retina.
  67. (2000). Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings.
  68. (2009). Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
  69. (1992). Variations in human liver fucosyltransferase activities in hepatobiliary diseases. Liver
  70. Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring.